tirzepatide effect on fertility for fertility-sparing treatment in obese/overweight patients with endometrial cancer and atypical hyperplasia: a phase II single-arm clinical trial protocol GLP-1 receptor agonists, semaglutide, liraglutide,
Description
Appetite (GLP-1) + insulin signaling (GIP) + fullness (amylin)
Patients should follow the storage instructions in the patient information leaflet provided with their medication
Significant weight loss typically occurs between 3 to 6 months as the medication takes full effect
This eliminates one of the most common sources of dosing errors in compounded tirzepatide, which is patients miscalculating draw volumes when concentrations change
No type of alcohol is truly risk-free while taking retatrutide
